Aprea Therapeutics Announces Closing of Oversubscribed $30 Million Private Placement
Aprea Therapeutics, a clinical-stage precision oncology company, closed an oversubscribed $30 million private placement led by top-tier biotech investors. The financing will support ongoing clinical trials, specifically advancing the ACESOT-1051 study targeting uterine serous carcinoma and platinum-resistant ovarian cancer with their investigationa…